Krister Wennerberg, PhD
Project 3 Co-Investigator
FIMM-EMBL Group Leader, University of Helsinki
The Cancer Chemical Systems Biology research group led by Krister Wennerberg focuses on gaining fundamental, novel understanding of cancers and their phenotypes by using a chemical systems biology approach. Through both 1) discovery and validation of novel oncology drug targets through the development of molecular probes and 2) utilization of collections of approved and investigational drugs on cancer cells, the research group aims to discover novel personalized therapeutic strategies and define and understand the molecular mechanisms driving the cancers, their drug responses and mechanisms of resistance.
Wennerberg Lab (external link)